Value proposition

America's leading nonprofit investor in medical research aimed at finding better treatments and a cure for scleroderma.

The Scleroderma Research Foundation (SRF) is America's leading nonprofit investor in medical research to discover improved treatments and a cure for scleroderma.

Our collaborative model for medical research brings together the best in science and technology for the benefit of scleroderma patients.

The SRF was established in 1987 by patient turned activist Sharon Monsky, when research on this potentially life threatening illness was nearly nonexistent. Since inception, we’ve stood firm in our belief that the best way to help scleroderma patients is to fund medical research aimed at better therapies and a cure. Patients and their loved ones find hope in the fact the SRF is dedicated exclusively to funding medical research that will help them live longer, fuller lives.

Led by a Scientific Advisory Board comprised of some of the world's most highly respected medical experts, the SRF continues to expand a research portfolio that aims to understand what causes scleroderma, how it progresses and how we can not only halt, but also reverse the disease process.

The SRF is responsible for helping to launch and support two of the world's most respected Scleroderma Centers of Excellence at The Johns Hopkins University School of Medicine and at Stanford University.

Cool Comedy - Hot Cuisine is the SRF's high-profile, signature event, featuring world class performances by headlining comedians and special musical guests along with gourmet food prepared by celebrity chefs. The event takes place in Las Vegas, Los Angeles, New York and San Francisco.

Thanks in large part to the SRF, its supporters and its partners across academia and industry, research is progressing at a faster pace than ever before.

Medical research, Raynaud's phenomenon, Scleroderma, Autoimmune disease, and Cool Comedy - Hot Cuisine Event